Search research articles
Contact Us
Filters
Showing results (211-220 of 219) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 219 results.
Journal of Virology
|
February 11, 2025
Activation of CXCR3<sup>+</sup> Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development
Julie L Mitchell, Supranee Buranapraditkun, Pierre Gantner, et al.
Science Translational Medicine
|
March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection
Louise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus
Joanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
Plos Pathogens
|
December 16, 2014
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation
Alexandra Schuetz, Claire Deleage, Irini Sereti, et al.
Plos Medicine
|
April 21, 2005
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
Rami Kantor, David A Katzenstein, Brad Efron, et al.
Journal of Virus Eradication
|
November 30, 2020
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
Eugène D M B Kroon, Jintanat Ananworanich, Amélie Pagliuzza, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2006
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent
Joke Snoeck, Rami Kantor, Robert W Shafer, et al.
The Journal of Clinical Investigation
|
November 11, 2021
Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
Julie L Mitchell, Justin Pollara, Kenneth Dietze, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries
, Dorita Avila, Keri N Althoff, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 219) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 219 results.
Journal of Virology
|
February 11, 2025
Activation of CXCR3<sup>+</sup> Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development
Julie L Mitchell, Supranee Buranapraditkun, Pierre Gantner, et al.
Science Translational Medicine
|
March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection
Louise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus
Joanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
Plos Pathogens
|
December 16, 2014
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation
Alexandra Schuetz, Claire Deleage, Irini Sereti, et al.
Plos Medicine
|
April 21, 2005
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
Rami Kantor, David A Katzenstein, Brad Efron, et al.
Journal of Virus Eradication
|
November 30, 2020
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
Eugène D M B Kroon, Jintanat Ananworanich, Amélie Pagliuzza, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2006
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent
Joke Snoeck, Rami Kantor, Robert W Shafer, et al.
The Journal of Clinical Investigation
|
November 11, 2021
Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
Julie L Mitchell, Justin Pollara, Kenneth Dietze, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries
, Dorita Avila, Keri N Althoff, et al.
Page
of 22